Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-26T09:56:50.279Z Has data issue: false hasContentIssue false
  • English
  • Français

Empiric Management of Cyanide Toxicity Associated with Smoke Inhalation

Published online by Cambridge University Press:  26 November 2011

Daniel J. O’Brien ,
Donald W. Walsh ,
Colleen M. Terriff  and
Alan H. Hall
Daniel J. O’Brien*
Affiliation:
Associate Professor of Emergency Medicine, Department of Emergency Medicine, University of Louisville School of Medicine, Louisville, Kentucky USA
Donald W. Walsh
Affiliation:
International Emergency Medicine & Disaster Specialists, Chicago Fire Department Emergency Medical Services Division Chief (Retired), Chicago, Illinois USA
Colleen M. Terriff
Affiliation:
Clinical Associate Professor, Washington State University College of Pharmacy, Deaconess Medical Center, Spokane, Washington USA
Alan H. Hall
Affiliation:
President and Chief Medical Toxicologist, Toxicology Consulting and Medical Translating Services, Inc., Laramie, Wyoming; Clinical Assistant Professor, Colorado School of Public Health, Denver, Colorado USA
*
Correspondence: Daniel J. O’Brien, MD, FACEP Associate Professor of Emergency Medicine Department of Emergency Medicine530 South Jackson StreetLouisville, Kentucky 40202 USA E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Enclosed-space smoke inhalation is the fifth most common cause of all unintentional injury deaths in the United States. Increasingly, cyanide has been recognized as a significant toxicant in many cases of smoke inhalation. However, it cannot be emergently verified. Failure to recognize the possibility of cyanide toxicity may result in inadequate treatment. Findings suggestive cyanide toxicity include: (1) a history of an enclosed-space fire scene in which smoke inhalation was likely; (2) the presence of oropharyngeal soot or carbonaceous expectorations; (3) any alteration of the level of consciousness, and particularly, otherwise inexplicable hypotension (systolic blood pressure ≤90 mmHg in adults). Prehospital studies have demonstrated the feasibility and safety of empiric treatment with hydroxocobalamin for patients with suspected smoke inhalation cyanide toxicity. Although United States Food and Drug Administration (FDA)-approved since 2006, the lack of efficacy data has stymied the routine use of this potentially lifesaving antidote. Based on a literature review and on-site observation of the Paris Fire Brigade, emergency management protocols to guide empiric and early hydroxocobalamin administration in smoke inhalation victims with high-risk presentations are proposed.

Keywords

cyanide toxicityhydroxocobalaminprehospital management smoke inhalation
Type
Comprehensive Review
Information
Prehospital and Disaster Medicine , Volume 26 , Issue 5 , October 2011 , pp. 374 - 382
Copyright
Copyright O’Brien © World Association for Disaster and Emergency Medicine 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

CDC: Fire deaths and injuries: Fact sheet. Available at http://www.cdc.gov/ncipc/factsheets/fire/htm. Accessed 03 November 2009.Google Scholar
Hall, JR: Burns, Toxic Gases, and Other Hazards Associated with Fires: Deaths and Injuries in Fire and Non-Fire Situations. Quincy, MA: National fire Protection Association, Fire Analysis and Research Division, 2001.Google Scholar
Chaturvedi, AK: Aviation combustion toxicology: An overview. J Anal Toxicol 2010;34:1–16.CrossRefGoogle ScholarPubMed
Shusterman, D, Alexeff, G, Hargis, C, et al: Predictions of carbon monoxide and hydrogen cyanide exposure in smoke inhalation patients. Clin Toxicol 1996;34:61–71.Google ScholarPubMed
Bizovi, KE, Leikin, JD: Smoke inhalation among firefighters. Occup Med 1995;10:721–733.Google Scholar
Symington, IS, Anderson, RA, Thomson, I, et al: Cyanide exposure in fires. Lancet 1978;2:91.CrossRefGoogle ScholarPubMed
Miller, K, Chang, A: Acute inhalation injury. Emerg Med Clin N Am. 2003;21:533–557.Google Scholar
Alarie, Y: Toxicology of fire smoke. Crit Rev Toxicol 2002;32:259–289.CrossRefGoogle Scholar
Barillo, DJ, Goode, R, Esch, V: Cyanide poisoning in victims of fire: analysis of 364 cases and review of the literature. J Burn Care Rehabil 1994;15:46–57.CrossRefGoogle ScholarPubMed
Gill, JR, Goldfeder, LB, Stajic, M: The happy land homicides: 87 deaths due to smoke inhalation. J Forensic Sci 2003;48:161–163.CrossRefGoogle ScholarPubMed
Silverman, SH, Purdue, GF, Hunt, JL, et al: Cyanide toxicity in burned patients. J Trauma. 1988;28:171–176.CrossRefGoogle ScholarPubMed
Baud, FJ, Barriot, P, Toffis, V, et al: Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 1991;325:1761–1766.CrossRefGoogle ScholarPubMed
Lindquist, P, Rammer, L, Sorbo, B: The role of hydrogen cyanide and carbon monoxide in fire casualties: A prospective study. Forens Sci Int 1989;43:9–14.Google Scholar
Barillo, DJ, Goode, R, Rush, BF, et al: Lack of correlation between carboxyhemoglobin and cyanide in smoke inhalation injury. Curr Surg 1986;43:421–423.Google ScholarPubMed
Warburg, O, Posener, K, Negelein, E: Ueber den stoffweschel der tumoren [On the metabolism of tumors] [German]. Biochem. Zeitsch. 1924;152:319–344.Google Scholar
Hall, AH: Cyanide and related compounds – sodium azide. In: Shannon, MW, Borron, SW, Burns, MJ, eds. Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose. 4th ed. Philadelphia: Saunders Elsevier; 2007: pp 1309–1316.Google Scholar
Mégarbane, B, Delahaye, A, Goldgran-Tolédano, D, et al: Antidotal treatment of cyanide poisoning. J Chin Med Assoc 2003;66:193–203.Google Scholar
Baud, FJ, Borron, SW, Bavoux, E, et al: Relation between plasma lactate and blood cyanide concentrations in acute cyanide poisoning. Br Med J 1996;312:1039.Google Scholar
Baud, FJ, Borron, SW, Megarbane, B, et al: Value of lactic acidosis in the assessment of severity of acute cyanide poisoning. Crit Care Med 2002;30(9):2044–2050.Google Scholar
Benaissa, ML, Mégarbane, B, Borron, SW, et al: Is elevated plasma lactate a useful marker in the evaluation of pure carbon monoxide poisoning? Intensive Care Med 2003;29:1372–1375.CrossRefGoogle ScholarPubMed
Varone, JC, Warren, TN, Jutras, K, et al: Report of the Investigation Committee into the Cyanide Poisonings of Providence Firefighters. A Report submitted to David D. Costa, Chief of Department and President Paul Doughty, IAFF Local 997, May 20, 2006, 99 pp.Google Scholar
Cyanide Poisoning. Available at http://www.manbir-online.com/diseases/cyanide.htm. Accessed 01 October 2010.Google Scholar
Hall, AH, Dart, R, Bogdan, G: Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Emerg Med 2007;49:806–813.CrossRefGoogle ScholarPubMed
Wolf, SJ, Lavonas, EJ, Sloan, EP, et al: American College of Emergency Physicians. Clinical policy: Critical issues in the management of adult patients presenting to the emergency department with acute carbon monoxide poisoning. Ann Emerg Med 2008;51(2):138–152.CrossRefGoogle Scholar
Juurlink, DN, Buckly, N, Stanbrook, MB, et al: Hyperbaric Oxygen for Carbon Monoxide Poisoning (review). New York: John Wiley & Sons, Ltd., 2009.Google Scholar
Fortin, JL, Giocanti, PJ, Ruttimann, M, et al: Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: Eight years of experience in the Paris Fire Brigade. Clin Toxicol. 2006;44 Suppl 1:37–44.Google Scholar
Borron, SW, Baud, FJ, Barriot, P, et al: Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2007; 49:794–801.CrossRefGoogle ScholarPubMed
Forsyth, JC, Mueller, PD, Becker, CE, et al: Hydroxocobalamin as a cyanide antidote: Safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol. 1993;31:277–294.Google Scholar
Uhl, W, Nolting, A, Golor, G, et al: Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol 2006;44(Suppl):17–28.Google Scholar
Uhl, W, Nolting, A, Gallemann, P, et al: Changes in blood pressure after administration of hydroxocobalamin: Relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers. Clin Toxicol 2008;46:551–559.Google Scholar
Curry, SC, Connor, DA, Raschke, RA: Effect of the canide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med 1994;24:65–67.CrossRefGoogle Scholar
Gourlain, J, Caliez, C, Laforge, M, et al: Study of the mechanisms involved in hydroxocobalamin interference with determination of some biochemical parameters. Ann Biol Clin (Paris) 1994;52:118–119.Google ScholarPubMed
Package Insert. Cyanokit (hydroxocobalamin 5-grams). Dey L.P., December 2006, Napa, CA.Google Scholar
Breton, D, Jouvet, P, de Blic, J, et al: [Toxicity of fire smoke: A propos of 2 pediatric cases] [French]. Arch Fr Pediatr 1993;50:43–45.Google Scholar
Haouach, H, Fortin, JL, LaPostolle, F: Prehospital use of hydroxocobalamin in children exposed to fire smoke. Ann Emerg Med 2005;46:530 (Abstract).CrossRefGoogle Scholar
Geller, RJ, Berthold, C, Saires, JA, et al: Pediatric cyanide poisoning: Causes, manifestations, management, and unmet needs. Pediatrics 2006;118:2146–2158.Google Scholar
Swanson-Bierman, B, Krenzelok, EP, Snyder, JW, et al: Successful donation and transplantation of multiple organs from a victim of cyanide poisoning. Clin Toxicol 1993;31:95.Google Scholar
Hantson, P, Mahieu, P, Hassoun, A, et al: Outcome following organ removal from poisoned donors in brain death status: A report of 12 cases and review of the literature. Clin Toxicol. 1995;33:709.Google ScholarPubMed
Gerth, K, Ehring, T, Braendle, M, et al: Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile. Clin Toxicol. 2006;44(suppl 1):29–36.CrossRefGoogle ScholarPubMed
Greenberg, SS, Xie, J, Zatarain, JM, et al: Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension and mortality in todents: role of nitric oxide. J Pharmacol Exp Ther 1995;273:257–265.Google ScholarPubMed
US Food and Drug Administration: FDA news: FDA approves drug to treat cyanide poisoning. Available at http://www.fda.gov/bbs/topics/NEWS/2006/NEW01531.html. Accessed 01 October 2010.Google Scholar
Fortin, JL, Desmettre, T, Manzon, C, et al: Cyanide poisoning and cardiac disorders: 161 cases. J Emerg Med 2010;38:467–476.Google Scholar
Erdman, AR: Is hydroxocobalamin safe and effective for smoke inhalation? Searching for guidance through the haze. Ann Emerg Med 2007;49:814–816.CrossRefGoogle ScholarPubMed
Shepard, G, Velez, LI: Role of hydroxocobalamin in acute cyanide poisoning. Ann Pharmacother 2008;42:661–669.Google Scholar